On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Insulet produces and sells Omnipod, an automated insulin delivery device, which works without the external tubing required by conventional pumps and eliminates the need for multiple daily ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

GCC Syringes and Needles MarketThe market for syringes and needles in the Gulf Cooperation Council (GCC) region is poised for ...

Insulet (PODD) shares jumped 9.4% after the maker of insulin delivery devices posted better-than-expected quarterly sales and profits, driven by record year-over-year revenue growth. The company ...